Comparing two laser wavelengths for treating varicose veins
Official title: Randomized Comparative Study With Two Wavelengths 1470 nm and 1940 nm for the Treatment of Varicose Veins of the Lower Limbs by Endovenous Laser.
Run by Clinique Pasteur · NCT05663359 · Data updated 2026-11-12
This study is testing whether using two different laser wavelengths to treat varicose veins can help patients feel better and have fewer complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 280 (estimated) |
| Sponsor | Clinique Pasteur Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | February 24, 2023 |
| Main results expected | February 2032 |
| Study ends | February 2032 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT05663359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with primary insufficiency of the great saphenous vein or small saphenous vein, with a vein diameter of 3 mm or greater.
✕Probably not a fit
Patients with serious underlying health conditions, recent vein thrombosis, or specific vascular issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of two different wavelengths (1940 nm and 1470 nm) used in Endovenous Laser Ablation (EVLA) for treating varicose veins in the lower limbs. The study will assess whether the higher wavelength improves treatment efficacy and reduces complications or pain compared to the lower wavelength. Participants will undergo laser ablation and will be monitored for five years to evaluate clinical outcomes, potential complications, and quality of life. The trial will involve patients with primary insufficiency of the great or small saphenous veins who meet specific inclusion criteria.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with varicose veins, potentially enhancing efficacy and reducing complications.
How similar studies have gone: While there have been studies on EVLA, this specific comparison of wavelengths is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Primary insufficiency of the great saphenous vein (GSV) and/or small saphenous vein (SSV) * Patient candidate for endothermic treatment of the lower limbs * CEAP: C2 - C6 * Patient with a target vein diameter (GSV and/or SSV) \>= 3 mm throughout the target vein segment * Patient affiliated or beneficiary of a social security scheme * Patient having signed the informed consent Exclusion Criteria: * Patient with a current serious pathology and/or a life expectancy of less than 5 years * Patient who has had a deep or superficial vein thrombosis in the previous 6 months * Obliterating arteriopathy of the lower limb concerned, with an IPS \< 0.8 or \> 1.3 * Patient with post-thrombotic obstructive syndrome at the popliteal and/or femoral and/or iliac stage on the ipsilateral lower limb * Patient with primary or post-thrombotic axial deep venous reflux on the ipsilateral lower limb * Suspicion of non-post-thrombotic iliac compression on echo-doppler * Contraindication to the planned treatment technique * Patient whose geographical distance is not compatible with the follow-up of the study * Pregnant or breastfeeding women * Patient linguistically or psychologically unable to understand the information given, to give informed consent or to answer the study questionnaires. * Protected patients: Adults under guardianship, or other legal protection; Hospitalized without consent.
Where it's running
-
Clinique Pasteur
Toulouse, France Recruiting
Study contacts
- Principal investigator: Nicolas NEAUME, MD — Clinique Pasteur
- Study coordinator: Nicolas NEAUME, MD
- Email: nneaume@clinique-pasteur.com
- Phone: +33 5 61 16 13 03
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ITHBC-based nursing program to support self-care after leg varicose vein surgery
This project will try a nursing program based on ITHBC theory to help adults manage their recovery and self-care after surgery for varicose veins in the legs.
-
Laser crossectomy with 1470 nm versus 1940 nm to prevent varicose vein recurrence
This will test whether doing a flush laser crossectomy with either a 1470 nm or 1940 nm laser lowers the chance of varicose vein recurrence and heat-related clots in adults with great saphenous vein reflux.
-
Polidocanol foam with or without transdermal Nd:YAG 1064 nm laser for lower‑leg varicose veins
This trial will test whether adding a transdermal Nd:YAG 1064 nm laser to polidocanol foam sclerotherapy helps close and improve the appearance of lower‑leg varicose veins in adults.
-
Vacuum-assisted Laser Ablation for large saphenous veins
This study is testing a new method called vacuum-assisted laser ablation to see if it works better and is safer than the traditional method for treating large varicose veins.
-
Preventing blood clots in patients undergoing varicose vein treatment
This study tests different blood-thinning medications to see which one best helps prevent blood clots in adults getting treatment for varicose veins.
-
Validation of Caprini Score for Patients Undergoing Varicose Vein Surgery
This study is testing if the Caprini score can help identify adults having varicose vein surgery who are at higher risk for blood clots after their procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.